Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMUGENE LIMITED Director's Dealing 2023

Oct 3, 2023

65124_rns_2023-10-03_5516399e-761a-4d3f-9898-c9ce61d06e08.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director's Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX becomes ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Imugene Limited
ABN 99 009 179 551

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director Paul Hopper
Date of last notice 30 June 2023

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest Direct and Indirect
Nature of indirect interest
(including registered holder)
Director related parties
Date of change (1) N/A
(2) N/A
(3) N/A
(4) 26 September 2023
(5) 03 October 2023
(6) 03 October 2023
No. of securities held prior to change (1) Direct Shares: 2,358,600
(2) Indirect Shares - 314,773,048
(3) Indirect Options - 2,900,000
Class (1) ORDINARY FULLY PAID SHARES
(2) ORDINARY FULLY PAID SHARES
(3) OPTIONS
(4) ORDINARY FULLY PAID SHARES
(5) ORDINARY FULLY PAID SHARES
(6) LISTED OPTIONS @ $0.0118, expiring 31
August 2026
  • See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director's Interest Notice

Appendix 3Y
Change of Director's Interest Notice
Number acquired (1) NIL
(2) NIL
(3) NIL
(4) 535,714 - ORDINARY FULLY PAID SHARES
(5) 2,380,952 - ORDINARY FULLY PAID SHARES
(6) 2,380, 952 - LISTED OPTIONS @ $0.0118,
expiring 31 August 2026
Number disposed NIL
Value/Consideration (1) N/A
(2) N/A
(3) N/A
(4) $0.056 - ORDINARY FULLY PAID SHARES
(5) $0.084 - ORDINARY FULLY PAID SHARES
(6) NIL - Free attachment placement options
No. of securities held after change (1) Direct Shares: 2,358,600
(2) Indirect Shares - 314,773,048
(3) Indirect Options - 2,900,000
(4) 2,894,314 - ORDINARY FULLY PAID SHARES
(5) 2,380,952 - ORDINARY FULLY PAID SHARES
(6) 2,380,952 - LISTED OPTIONS @ $0.0118,
expiring 31 August 2026
Nature of change Participation in Placement and Securities Purchase
Plan announced 18 August 2023 and as approved
by shareholders at the EGM held on 28 September
2023.

Part 2 - Change of director's relevant interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
Date of change N/A
No. and class of securities
to which interest related
prior to change
N/A
Interest acquired N/A
Interest disposed N/A
Value/Consideration N/A
Interest after change N/A

Part 3 -[+] Closed period

  • See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 2

Appendix 3Y Change of Director's Interest Notice

Were the interests in the securities or
contracts detailed above traded during a
+closed period where prior written clearance
was required?
NO
If so, was prior written clearance provided to
allow the trade to proceed during this period?
N/A
If prior written clearance was provided, on
what date was this provided?
N/A
  • See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 3